Managing vascular access device occlusions, Part. 1.
Hadaway
L C
LC
Hadaway & Associates, Milner, Ga., USA.
D002405:Catheterization, Central Venous / Q000009:adverse effects* / Q000451:nursing*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D004868:Equipment Failure; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D013927:Thrombosis / Q000209:etiology* / Q000451:nursing / Q000517:prevention & control*
D005343:Fibrinolytic Agents